annual CFI:
-$1.77B+$629.18M(+26.17%)Summary
- As of today (August 20, 2025), GSK annual cash flow from investing activities is -$1.77 billion, with the most recent change of +$629.18 million (+26.17%) on December 31, 2024.
- During the last 3 years, GSK annual CFI has risen by +$691.04 million (+28.02%).
- GSK annual CFI is now -119.58% below its all-time high of $9.06 billion, reached on December 31, 2015.
Performance
GSK Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$824.98M+$755.46M(+47.80%)Summary
- As of today (August 20, 2025), GSK quarterly cash flow from investing activities is -$824.98 million, with the most recent change of +$755.46 million (+47.80%) on June 30, 2025.
- Over the past year, GSK quarterly CFI has dropped by -$1.75 billion (-189.22%).
- GSK quarterly CFI is now -107.74% below its all-time high of $10.66 billion, reached on March 31, 2015.
Performance
GSK quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$4.87B-$1.75B(-56.12%)Summary
- As of today (August 20, 2025), GSK TTM cash flow from investing activities is -$4.87 billion, with the most recent change of -$1.75 billion (-56.12%) on June 30, 2025.
- Over the past year, GSK TTM CFI has dropped by -$5.16 billion (-1765.21%).
- GSK TTM CFI is now -152.17% below its all-time high of $9.33 billion, reached on March 31, 2015.
Performance
GSK TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
GSK Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.2% | -189.2% | -1765.2% |
| 3 y3 years | +28.0% | -41.5% | +35.3% |
| 5 y5 years | +74.5% | -123.2% | -295.4% |
GSK Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +83.7% | -189.2% | +83.5% | -1765.2% | +55.3% |
| 5 y | 5-year | -166.1% | +83.7% | -123.2% | +83.5% | -278.5% | +55.3% |
| alltime | all time | -119.6% | +87.9% | -107.7% | +93.8% | -152.2% | +74.8% |
GSK Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$824.98M(-47.8%) | -$4.87B(+56.1%) |
| Mar 2025 | - | -$1.58B(+4.7%) | -$3.12B(+74.0%) |
| Dec 2024 | -$1.77B(-26.2%) | -$1.51B(+58.5%) | -$1.79B(<-9900.0%) |
| Sep 2024 | - | -$952.61M(-203.0%) | $9.36M(-96.8%) |
| Jun 2024 | - | $924.65M(-462.8%) | $292.30M(-114.9%) |
| Mar 2024 | - | -$254.86M(-187.2%) | -$1.96B(-17.9%) |
| Dec 2023 | -$2.40B(-77.9%) | $292.18M(-143.6%) | -$2.39B(-22.1%) |
| Sep 2023 | - | -$669.67M(-49.7%) | -$3.07B(-58.6%) |
| Jun 2023 | - | -$1.33B(+94.6%) | -$7.41B(+11.2%) |
| Mar 2023 | - | -$684.07M(+77.7%) | -$6.66B(-38.3%) |
| Dec 2022 | -$10.88B(+341.3%) | -$385.03M(-92.3%) | -$10.79B(-0.8%) |
| Sep 2022 | - | -$5.01B(+758.6%) | -$10.88B(+44.6%) |
| Jun 2022 | - | -$583.22M(-87.9%) | -$7.52B(+4.3%) |
| Mar 2022 | - | -$4.82B(+920.4%) | -$7.21B(+192.9%) |
| Dec 2021 | -$2.47B(-191.8%) | -$472.18M(-71.4%) | -$2.46B(+21.1%) |
| Sep 2021 | - | -$1.65B(+502.8%) | -$2.03B(+84.7%) |
| Jun 2021 | - | -$273.59M(+304.9%) | -$1.10B(-140.4%) |
| Mar 2021 | - | -$67.57M(+59.2%) | $2.73B(+1.6%) |
| Dec 2020 | $2.69B(-138.6%) | -$42.44M(-94.1%) | $2.68B(+15.8%) |
| Sep 2020 | - | -$717.14M(-120.2%) | $2.32B(-6.9%) |
| Jun 2020 | - | $3.55B(-3297.3%) | $2.49B(-236.7%) |
| Mar 2020 | - | -$111.16M(-72.8%) | -$1.82B(-73.5%) |
| Dec 2019 | -$6.95B(-52.4%) | -$408.20M(-25.0%) | -$6.89B(-1.6%) |
| Sep 2019 | - | -$544.16M(-28.3%) | -$7.00B(+3.4%) |
| Jun 2019 | - | -$758.83M(-85.3%) | -$6.77B(-64.9%) |
| Mar 2019 | - | -$5.18B(+894.4%) | -$19.30B(+31.2%) |
| Dec 2018 | -$14.62B(+646.3%) | -$520.62M(+67.2%) | -$14.72B(+0.2%) |
| Sep 2018 | - | -$311.47M(-97.7%) | -$14.69B(-1.9%) |
| Jun 2018 | - | -$13.29B(+2142.0%) | -$14.98B(+559.9%) |
| Mar 2018 | - | -$592.81M(+20.5%) | -$2.27B(+16.2%) |
| Dec 2017 | -$1.96B(+5.5%) | -$491.96M(-18.2%) | -$1.95B(+16.4%) |
| Sep 2017 | - | -$601.40M(+3.1%) | -$1.68B(+28.5%) |
| Jun 2017 | - | -$583.43M(+111.1%) | -$1.30B(+12.3%) |
| Mar 2017 | - | -$276.33M(+27.9%) | -$1.16B(-37.4%) |
| Dec 2016 | -$1.86B(-120.5%) | -$216.07M(-5.7%) | -$1.86B(-20.4%) |
| Sep 2016 | - | -$229.03M(-48.0%) | -$2.33B(-2.0%) |
| Jun 2016 | - | -$440.40M(-54.6%) | -$2.38B(-6.0%) |
| Mar 2016 | - | -$970.28M(+40.1%) | -$2.53B(-127.8%) |
| Dec 2015 | $9.06B(-580.4%) | -$692.57M(+150.1%) | $9.10B(-0.4%) |
| Sep 2015 | - | -$276.89M(-53.3%) | $9.14B(+1.2%) |
| Jun 2015 | - | -$593.12M(-105.6%) | $9.04B(-3.1%) |
| Mar 2015 | - | $10.66B(-1736.7%) | $9.33B(-408.9%) |
| Dec 2014 | -$1.89B(+754.5%) | -$651.62M(+70.2%) | -$3.02B(-895.0%) |
| Sep 2014 | - | -$382.84M(+27.5%) | $379.90M(-845.3%) |
| Jun 2014 | - | -$300.18M(-82.2%) | -$50.97M(-89.9%) |
| Mar 2014 | - | -$1.69B(-161.3%) | -$505.85M(+129.1%) |
| Dec 2013 | -$220.83M(-94.9%) | $2.75B(-437.8%) | -$220.83M(-93.5%) |
| Sep 2013 | - | -$813.71M(+7.8%) | -$3.39B(-47.0%) |
| Jun 2013 | - | -$755.06M(-46.1%) | -$6.39B(+8.1%) |
| Mar 2013 | - | -$1.40B(+234.7%) | -$5.91B(+37.0%) |
| Dec 2012 | -$4.31B(+1049.4%) | -$418.37M(-89.0%) | -$4.31B(-8.4%) |
| Sep 2012 | - | -$3.81B(+1266.8%) | -$4.71B(+257.0%) |
| Jun 2012 | - | -$279.02M(-242.1%) | -$1.32B(-10.8%) |
| Mar 2012 | - | $196.39M(-124.2%) | -$1.48B(+292.4%) |
| Dec 2011 | -$375.12M | -$812.40M(+91.7%) | -$376.72M(-28.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | -$423.83M(-3.3%) | -$524.48M(-40.4%) |
| Jun 2011 | - | -$438.31M(-133.8%) | -$880.40M(-29.3%) |
| Mar 2011 | - | $1.30B(-235.2%) | -$1.24B(-59.5%) |
| Dec 2010 | -$3.08B(-52.4%) | -$960.16M(+23.1%) | -$3.08B(-6.6%) |
| Sep 2010 | - | -$779.75M(-2.8%) | -$3.29B(-48.0%) |
| Jun 2010 | - | -$802.49M(+50.3%) | -$6.34B(+6.0%) |
| Mar 2010 | - | -$533.79M(-54.7%) | -$5.98B(-7.5%) |
| Dec 2009 | -$6.47B(+47.2%) | -$1.18B(-69.2%) | -$6.47B(-5.7%) |
| Sep 2009 | - | -$3.83B(+758.7%) | -$6.86B(+87.3%) |
| Jun 2009 | - | -$445.47M(-56.2%) | -$3.66B(-23.1%) |
| Mar 2009 | - | -$1.02B(-35.1%) | -$4.76B(+8.5%) |
| Dec 2008 | -$4.39B(-32.9%) | -$1.57B(+149.2%) | -$4.39B(-23.1%) |
| Sep 2008 | - | -$629.43M(-59.3%) | -$5.71B(-4.1%) |
| Jun 2008 | - | -$1.55B(+139.5%) | -$5.95B(+15.4%) |
| Mar 2008 | - | -$646.17M(-77.6%) | -$5.16B(-21.4%) |
| Dec 2007 | -$6.54B(+93.6%) | -$2.89B(+231.6%) | -$6.57B(+27.4%) |
| Sep 2007 | - | -$871.36M(+15.6%) | -$5.15B(-1.8%) |
| Jun 2007 | - | -$753.70M(-63.2%) | -$5.25B(+5.4%) |
| Mar 2007 | - | -$2.05B(+38.6%) | -$4.98B(+48.5%) |
| Dec 2006 | -$3.38B(-5.2%) | -$1.48B(+53.1%) | -$3.35B(-21.8%) |
| Sep 2006 | - | -$965.95M(+98.3%) | -$4.29B(+9.8%) |
| Jun 2006 | - | -$487.13M(+15.3%) | -$3.91B(-2.1%) |
| Mar 2006 | - | -$422.34M(-82.5%) | -$3.99B(+11.7%) |
| Dec 2005 | -$3.56B(+76.2%) | -$2.42B(+313.5%) | -$3.57B(+137.6%) |
| Sep 2005 | - | -$584.22M(+2.7%) | -$1.50B(-22.4%) |
| Jun 2005 | - | -$569.01M(>+9900.0%) | -$1.94B(+11.5%) |
| Mar 2005 | - | -$3.80M(-98.9%) | -$1.74B(-13.1%) |
| Dec 2004 | -$2.02B(+31.7%) | -$346.65M(-66.0%) | -$2.00B(-14.6%) |
| Sep 2004 | - | -$1.02B(+176.0%) | -$2.34B(+38.3%) |
| Jun 2004 | - | -$369.13M(+38.5%) | -$1.69B(+8.6%) |
| Mar 2004 | - | -$266.51M(-61.3%) | -$1.56B(+2.6%) |
| Dec 2003 | -$1.54B(-10.2%) | -$688.64M(+86.2%) | -$1.52B(-4.4%) |
| Sep 2003 | - | -$369.76M(+57.8%) | -$1.59B(-1.6%) |
| Jun 2003 | - | -$234.34M(+3.0%) | -$1.62B(-4.8%) |
| Mar 2003 | - | -$227.59M(-70.0%) | -$1.70B(-0.9%) |
| Dec 2002 | -$1.71B(-51.2%) | -$758.43M(+91.6%) | -$1.71B(-24.8%) |
| Sep 2002 | - | -$395.77M(+25.0%) | -$2.28B(-14.5%) |
| Jun 2002 | - | -$316.51M(+29.8%) | -$2.66B(+21.7%) |
| Mar 2002 | - | -$243.86M(-81.6%) | -$2.19B(-37.4%) |
| Dec 2001 | -$3.51B(+788.3%) | -$1.32B(+69.3%) | -$3.50B(+20.3%) |
| Sep 2001 | - | -$781.24M(-592.9%) | -$2.91B(+54.1%) |
| Jun 2001 | - | $158.51M(-110.2%) | -$1.89B(+200.5%) |
| Mar 2001 | - | -$1.55B(+111.7%) | -$628.23M(-14.4%) |
| Dec 2000 | -$394.78M(-80.7%) | -$733.60M(-405.1%) | -$733.60M(<-9900.0%) |
| Sep 2000 | - | $240.46M(-83.0%) | $0.00(-100.0%) |
| Jun 2000 | - | $1.42B(-185.5%) | -$240.46M(-85.5%) |
| Mar 2000 | - | -$1.66B | -$1.66B |
| Dec 1999 | -$2.05B(+113.7%) | - | - |
| Dec 1998 | -$959.56M(+134.4%) | - | - |
| Dec 1997 | -$409.41M(+435.5%) | - | - |
| Dec 1996 | -$76.45M(-99.0%) | - | - |
| Dec 1995 | -$7.56B(-470.7%) | - | - |
| Jun 1994 | $2.04B(-247.9%) | - | - |
| Jun 1993 | -$1.38B(+111.6%) | - | - |
| Jun 1992 | -$652.10M(-43.2%) | - | - |
| Jun 1991 | -$1.15B | - | - |
FAQ
- What is GSK plc annual cash flow from investing activities?
- What is the all time high annual CFI for GSK plc?
- What is GSK plc annual CFI year-on-year change?
- What is GSK plc quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for GSK plc?
- What is GSK plc quarterly CFI year-on-year change?
- What is GSK plc TTM cash flow from investing activities?
- What is the all time high TTM CFI for GSK plc?
- What is GSK plc TTM CFI year-on-year change?
What is GSK plc annual cash flow from investing activities?
The current annual CFI of GSK is -$1.77B
What is the all time high annual CFI for GSK plc?
GSK plc all-time high annual cash flow from investing activities is $9.06B
What is GSK plc annual CFI year-on-year change?
Over the past year, GSK annual cash flow from investing activities has changed by +$629.18M (+26.17%)
What is GSK plc quarterly cash flow from investing activities?
The current quarterly CFI of GSK is -$824.98M
What is the all time high quarterly CFI for GSK plc?
GSK plc all-time high quarterly cash flow from investing activities is $10.66B
What is GSK plc quarterly CFI year-on-year change?
Over the past year, GSK quarterly cash flow from investing activities has changed by -$1.75B (-189.22%)
What is GSK plc TTM cash flow from investing activities?
The current TTM CFI of GSK is -$4.87B
What is the all time high TTM CFI for GSK plc?
GSK plc all-time high TTM cash flow from investing activities is $9.33B
What is GSK plc TTM CFI year-on-year change?
Over the past year, GSK TTM cash flow from investing activities has changed by -$5.16B (-1765.21%)